OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $46,236,856 | +36.8% | 3,743,875 | 0.0% | 6.17% | +34.2% |
Q2 2023 | $33,807,191 | +160.2% | 3,743,875 | 0.0% | 4.60% | +147.3% |
Q1 2023 | $12,991,246 | +41.6% | 3,743,875 | 0.0% | 1.86% | +72.9% |
Q4 2022 | $9,172,494 | -11.2% | 3,743,875 | 0.0% | 1.08% | -15.4% |
Q3 2022 | $10,333,000 | -32.2% | 3,743,875 | 0.0% | 1.27% | -54.6% |
Q2 2022 | $15,238,000 | -4.5% | 3,743,875 | 0.0% | 2.80% | +35.2% |
Q1 2022 | $15,949,000 | -54.5% | 3,743,875 | 0.0% | 2.07% | -42.8% |
Q4 2021 | $35,043,000 | -66.0% | 3,743,875 | 0.0% | 3.61% | -51.4% |
Q3 2021 | $103,181,000 | -1.5% | 3,743,875 | 0.0% | 7.44% | -15.5% |
Q2 2021 | $104,754,000 | -15.7% | 3,743,875 | 0.0% | 8.80% | -27.4% |
Q1 2021 | $124,222,000 | -31.0% | 3,743,875 | 0.0% | 12.12% | -21.4% |
Q4 2020 | $180,006,000 | – | 3,743,875 | – | 15.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 3,743,875 | $35,043,000 | 3.61% |
BVF INC/IL | 7,411,503 | $69,372,000 | 2.52% |
Kynam Capital Management, LP | 293,799 | $2,750,000 | 1.47% |
Cormorant Asset Management, LP | 2,169,871 | $20,310,000 | 1.21% |
VR Adviser, LLC | 816,651 | $7,644,000 | 1.04% |
Vivo Capital, LLC | 1,689,515 | $15,814,000 | 0.95% |
Octagon Capital Advisors LP | 231,417 | $2,166,000 | 0.42% |
HighVista Strategies LLC | 50,942 | $477,000 | 0.38% |
RA Capital Management | 2,150,404 | $20,128,000 | 0.36% |
Rhenman & Partners Asset Management AB | 500,000 | $4,700,000 | 0.31% |